Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists
Simola, NicolaFirst
Writing - Review & Editing
;Pinna, AnnalisaWriting - Original Draft Preparation
;Frau, LuciaWriting - Original Draft Preparation
;Costa, GiuliaWriting - Original Draft Preparation
;Marongiu, JacopoWriting - Original Draft Preparation
;Parekh, PathikWriting - Original Draft Preparation
;Serra, MarcelloWriting - Original Draft Preparation
;Morelli, Micaela
Last
Writing - Review & Editing
2021-01-01
Abstract
Based on several findings suggesting that the adenosinergic system is one of the most interesting in the field of neuroprotection in Parkinson’s disease, this chapter describes the functions of the purine adenosine and its A2A receptors in the central nervous system, with emphasis on their role in neuroprotection. The neuromodulatory role of A2A receptors and the preclinical and epidemiological studies on the mechanisms of the neuroprotective role of caffeine and urate, the final product of purine catabolism, are extensively discussed in the light of their potential modifying effects on Parkinson’s disease.File | Size | Format | |
---|---|---|---|
Simola et al 2021_HB of Neurotoxicity.pdf Solo gestori archivio
Type: versione editoriale
Size 424.51 kB
Format Adobe PDF
|
424.51 kB | Adobe PDF | & nbsp; View / Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.